 In Treatment Stage 2, subjects will begin to self-administer once daily outpatient doses of the study gel for 7 days. After completion of Stage 2 the subject will complete a Product Acceptability Questionnaire PAQ by CASI and return to clinic for evaluation and specimen collection Visit 5. 